These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18664943)

  • 1. Combining evidence for access to and benefits from antiretroviral treatment to inform planning.
    ; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J
    AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943
    [No Abstract]   [Full Text] [Related]  

  • 2. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 3. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
    Hetherington S
    Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 7. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 10. World Bank meeting concludes drug resistance should not prevent distribution of antiretroviral therapy to poor countries.
    Kuritzkes D; Lange J; Zewdie D
    Nat Med; 2003 Nov; 9(11):1343-4. PubMed ID: 14595419
    [No Abstract]   [Full Text] [Related]  

  • 11. Prioritizing antiretrovirals for second-line therapy in resource-limited countries.
    Naidoo K
    AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
    Ventelou B; Moatti JP; Videau Y; Kazatchkine M
    AIDS; 2008 Jan; 22(1):107-13. PubMed ID: 18090398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current world literature.
    Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond antiretroviral access: low-cost laboratory tests needed for the developing world.
    Majchrowicz M
    AIDS; 2003; 17 Suppl 4():S13-5. PubMed ID: 15080172
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine screening for HIV infection--timely and cost-effective.
    Bozzette SA
    N Engl J Med; 2005 Feb; 352(6):620-1. PubMed ID: 15703428
    [No Abstract]   [Full Text] [Related]  

  • 17. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the scale-up of antiretroviral therapy in South Africa through health system optimization.
    Barker PM; McCannon CJ; Mehta N; Green C; Youngleson MS; Yarrow J; Bennett B; Berwick DM
    J Infect Dis; 2007 Dec; 196 Suppl 3():S457-63. PubMed ID: 18181694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs and adherence to antiretroviral treatment].
    Ventura-Cerdá JM; Ayago-Flores D; Vicente-Escrig E; Mollá-Cantavella S; Alós-Almiñana M
    Farm Hosp; 2010; 34(6):284-92. PubMed ID: 20692861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
    Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
    AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.